These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

937 related articles for article (PubMed ID: 8242546)

  • 41. Superior survival in treatment of primary nonmetastatic pediatric osteosarcoma of the extremity.
    Wilkins RM; Cullen JW; Odom L; Jamroz BA; Cullen PM; Fink K; Peck SD; Stevens SL; Kelly CM; Camozzi AB
    Ann Surg Oncol; 2003 Jun; 10(5):498-507. PubMed ID: 12794015
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dose-intense ifosfamide/doxorubicin/cisplatin based chemotherapy for osteosarcoma in adults.
    Patel SJ; Lynch JW; Johnson T; Carroll RR; Schumacher C; Spanier S; Scarborough M
    Am J Clin Oncol; 2002 Oct; 25(5):489-95. PubMed ID: 12393991
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relationship between dose-intensity of treatment and outcome for patients with osteosarcoma of the extremity treated with neoadjuvant chemotherapy.
    Bacci G; Ferrari S; Longhi A; Forni C; Giacomini S; Lari S; Versari M
    Oncol Rep; 2001; 8(4):883-8. PubMed ID: 11410803
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs.
    Fuchs N; Bielack SS; Epler D; Bieling P; Delling G; Körholz D; Graf N; Heise U; Jürgens H; Kotz R; Salzer-Kuntschik M; Weinel P; Werner M; Winkler K
    Ann Oncol; 1998 Aug; 9(8):893-9. PubMed ID: 9789613
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response.
    Winkler K; Beron G; Delling G; Heise U; Kabisch H; Purfürst C; Berger J; Ritter J; Jürgens H; Gerein V
    J Clin Oncol; 1988 Feb; 6(2):329-37. PubMed ID: 2448428
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of preoperative radiotherapy in nonmetastatic high-grade osteosarcoma of the extremities for limb-sparing surgery.
    Dinçbaş FO; Koca S; Mandel NM; Hiz M; Dervişoğlu S; Seçmezacar H; Oksüz DC; Ceylaner B; Uzel B
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):820-8. PubMed ID: 15936566
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neoadjuvant chemotherapy for the treatment of osteosarcoma of the limbs. Preliminary results in 100 patients treated preoperatively with high doses of methotrexate i.v. followed by cisplatin (i.a.) and adriamycin.
    Bacci G; Picci P; Ruggieri P; Avella M; Mercuri M; Capanna R; Biagini R; Tienghi C; Mancini A; Brach del Prever A
    Chir Organi Mov; 1991; 76(1):1-16. PubMed ID: 1893781
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neoadjuvant high-dose methotrexate, cisplatin, and doxorubicin for the management of patients with nonmetastatic osteosarcoma.
    Weiner MA; Harris MB; Lewis M; Jones R; Sherry H; Feurer EJ; Johnson J; Lahman E
    Cancer Treat Rep; 1986 Dec; 70(12):1431-2. PubMed ID: 3466693
    [No Abstract]   [Full Text] [Related]  

  • 49. Results of methotrexate-etoposide-ifosfamide based regimen (M-EI) in osteosarcoma patients included in the French OS2006/sarcome-09 study.
    Gaspar N; Occean BV; Pacquement H; Bompas E; Bouvier C; Brisse HJ; Castex MP; Cheurfa N; Corradini N; Delaye J; Entz-Werlé N; Gentet JC; Italiano A; Lervat C; Marec-Berard P; Mascard E; Redini F; Saumet L; Schmitt C; Tabone MD; Verite-Goulard C; Le Deley MC; Piperno-Neumann S; Brugieres L; ; ;
    Eur J Cancer; 2018 Jan; 88():57-66. PubMed ID: 29190507
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Effectiveness and safety of polyethylene glycol liposome doxorubicin in the treatment of osteosarcoma].
    Yang YK; Xu HR; Huang Z; Li Y; Niu XH
    Zhonghua Zhong Liu Za Zhi; 2020 Aug; 42(8):692-696. PubMed ID: 32867464
    [No Abstract]   [Full Text] [Related]  

  • 51. Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group.
    Provisor AJ; Ettinger LJ; Nachman JB; Krailo MD; Makley JT; Yunis EJ; Huvos AG; Betcher DL; Baum ES; Kisker CT; Miser JS
    J Clin Oncol; 1997 Jan; 15(1):76-84. PubMed ID: 8996127
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial.
    Piperno-Neumann S; Le Deley MC; Rédini F; Pacquement H; Marec-Bérard P; Petit P; Brisse H; Lervat C; Gentet JC; Entz-Werlé N; Italiano A; Corradini N; Bompas E; Penel N; Tabone MD; Gomez-Brouchet A; Guinebretière JM; Mascard E; Gouin F; Chevance A; Bonnet N; Blay JY; Brugières L; ; ;
    Lancet Oncol; 2016 Aug; 17(8):1070-1080. PubMed ID: 27324280
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of chemotherapy combined with caffeine for osteosarcoma.
    Tsuchiya H; Yasutake H; Yokogawa A; Baba H; Ueda Y; Tomita K
    J Cancer Res Clin Oncol; 1992; 118(8):567-9. PubMed ID: 1517277
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Results of API-AI based regimen in osteosarcoma adult patients included in the French OS2006/Sarcome-09 study.
    Piperno-Neumann S; Ray-Coquard I; Occean BV; Laurence V; Cupissol D; Perrin C; Penel N; Bompas E; Rios M; Le Cesne A; Italiano A; Anract P; de Pinieux G; Collard O; Bertucci F; Duffaud F; Le Deley MC; Delaye J; Brugieres L; Blay JY
    Int J Cancer; 2020 Jan; 146(2):413-423. PubMed ID: 31246277
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Etoposide, cyclophosphamide, cisplatin, and doxorubicin as neoadjuvant chemotherapy for osteosarcoma.
    Cassano WF; Graham-Pole J; Dickson N
    Cancer; 1991 Nov; 68(9):1899-902. PubMed ID: 1913541
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neoadjuvant chemotherapy for osteosarcoma of the extremity: long-term results of the Rizzoli's 4th protocol.
    Bacci G; Briccoli A; Ferrari S; Longhi A; Mercuri M; Capanna R; Donati D; Lari S; Forni C; DePaolis M
    Eur J Cancer; 2001 Nov; 37(16):2030-9. PubMed ID: 11597381
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
    Kager L; Zoubek A; Pötschger U; Kastner U; Flege S; Kempf-Bielack B; Branscheid D; Kotz R; Salzer-Kuntschik M; Winkelmann W; Jundt G; Kabisch H; Reichardt P; Jürgens H; Gadner H; Bielack SS;
    J Clin Oncol; 2003 May; 21(10):2011-8. PubMed ID: 12743156
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neoadjuvant chemotherapy for nonmetastatic osteosarcoma of the extremities: the recent experience at the Rizzoli Institute.
    Bacci G; Picci P; Ferrari S; Avella M; Prever BA; Ruggieri P; Casadei R; Lari S; Monti C; Cazzola A
    Cancer Treat Res; 1993; 62():299-308. PubMed ID: 7682090
    [No Abstract]   [Full Text] [Related]  

  • 59. Comparative outcome of Thai pediatric osteosarcoma treated with two protocols: the role of high-dose methotrexate (HDMTX) in a single institute experience.
    Choeyprasert W; Pakakasama S; Sirachainan N; Songdej D; Chuansumrit A; Anurathapan U; Hongeng S; Nartthanarung A
    Asian Pac J Cancer Prev; 2014; 15(22):9823-9. PubMed ID: 25520112
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Osteosarcoma of the extremities with synchronous lung metastases: long-term results in 44 patients treated with neoadjuvant chemotherapy.
    Bacci G; Briccoli A; Mercuri M; Ferrari S; Bertoni F; Gasbarrini A; Fabbri N; Cesari M; Forni C; Campanacci M
    J Chemother; 1998 Feb; 10(1):69-76. PubMed ID: 9531078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.